Choose Your Language:
Applicable to patients in the United States only
In May 2022, TSF announced its partnership with The PAN Foundation to help people living with neuromyelitis optica spectrum disorder (NMOSD), providing up to $9,600 per year in financial assistance and support services for patients and their caregivers or loved ones.
Applicable to patients in the United States only
In August 2022, TSF announced its partnership with The Assistance Fund to help people living in the US with neuromyelitis optica spectrum disorder (NMOSD) by providing financial assistance and support services for patients and their caregivers or loved ones.
The program provides financial assistance with the following out-of-pocket costs:
Applicable to patients in the United States only
NORD’s Neuromyelitis Optica Spectrum Disorder (NMOSD) Patient Assistance Program is open and accepting applications for assistance. This program is designed to lessen the financial burden that may accompany having a rare diagnosis. To learn more, click the link below, email [email protected] and/or call (203) 202-8833
Applicable to patients in the United States only
In June 2024, TSF announced its partnership with Good Days to help people living in the US with neuromyelitis optica spectrum disorder (NMOSD) by providing financial assistance and support services for patients and their caregivers or loved ones.
Applicable to patients in the United States only
In October 2024, TSF announced its partnership with Patient Helpline, a program of Patients Rising, is a patient support and navigation program that provides online, email, and phone support to help connect patients to the services and guidance they need. They specialize in finding existing resources and providing expert advice (never medical advice) to chronic or rare illness patients and caregivers, and offer dispatch service (arrange and pay for transportation) to patients with low vision secondary to rare disease.
